MASTERKEY-232: T-VEC not the way forward in relapsed head and neck cancer

Kevin Harrington, PhD, MBBS, of the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK, presented data from the Phase Ib MASTERKEY-232 trial (NCT02626000) at the Ameri... Author: VJOncology Added: 07/27/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts